Jaymes S. Holland, John Duan, George Kraft. "A novel cabozantinib formulation with reduced pharmacokinetic variability and the potential to improve safety in patients with renal cell carcinoma.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.512